Foto del docente

Barbara Monti

Full Professor

Department of Pharmacy and Biotechnology

Academic discipline: BIO/09 Physiology

Head of Department of Pharmacy and Biotechnology

Publications

Albertini, C; Salerno, A; Atzenti, S; Uliassi, E; Massenzio, F; Maruca, A; Rocca, R; Mecava, M; Silva, FSG; Mena, D; Valente, P; Duarte, AI; Chavarria, D; Bissaro, M; Moro, S; Federico, S; Spalluto, G; Soukup, O; Borges, F; Alcaro, S; Monti, B; Oliveira, PJ; Menendez, JC; Bolognesi, ML, Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis, «ACS CHEMICAL NEUROSCIENCE», 2022, 13, pp. 2252 - 2260 [Scientific article]Open Access

Nozal, Vanesa; Martínez-González, Loreto; Gomez-Almeria, Marta; Gonzalo-Consuegra, Claudia; Santana, Paula; Chaikuad, Apirat; Pérez-Cuevas, Eva; Knapp, Stefan; Lietha, Daniel; Ramírez, David; Petralla, Sabrina; Monti, Barbara; Gil, Carmen; Martín-Requero, Angeles; Palomo, Valle; de Lago, Eva; Martinez, Ana, TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy, «JOURNAL OF MEDICINAL CHEMISTRY», 2022, Online ahead of print., pp. 1 - 23 [Scientific article]Open Access

Nicola Marini, Andrea Miti, Francesca De Chirico, Francesca Massenzio, Sabrina Petralla, Barbara Monti, Giampaolo Zuccheri, Tampering with microglia-mediated neuroinflammation by means of DNA nanostructures, in: AA.VV., Abstract booklet for DNA Nanotechnology 2022: “DNA hybrid structures”, Jena, 2022, pp. 42 - 42 (atti di: DNA Nanotechnology 2022: “DNA hybrid structures”, Jena, Germany, 12-14/05/2022) [Abstract]

Coordination of a Research Project: Telethon GGP19067-2019 - "Alla ricerca di nuovi bersagli terapeutici per contrastare l’ipomielinizzazione nell’AGC1 deficiency: uno studio multidisciplinare sui precursori delle cellule cerebrali"..

Martina Fazzina, Francesca Massenzio, Barbara Monti, Matteo Bergonzoni, Davide Maestri, Flavia Frabetti, Raffaella Casadei, Up-regulation of LINC00520 in in vitro models of Parkinson's disease: searching for a physiological role and dysregulation in neurodegeneration, in: Abstract book - XX Congresso Nazionale A.I.B.G. - Roma, 23-24 Settembre 2022, 2022, pp. 62 - 62 (atti di: XX Congresso Nazionale A.I.B.G., Roma, 23-24 Settembre 2022) [Abstract]

Sabrina Petralla, Cristina Parenti, Valentina Ravaioli, Irene Fancello, Francesca Massenzio, Marco Virgili, Barbara Monti, Emiliano Pena-Altamira, Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia, «MOLECULAR NEUROBIOLOGY», 2021, 58, Article number: 19 , pp. 1312 - 1329 [Scientific article]

Martina Fazzina, Letizia Pruccoli, Andrea Tarozzi, Francesca Massenzio, Barbara Monti, Davide Maestri, Matteo Bergonzoni, Flavia Frabetti, Raffaella Casadei, Dysregulation of long non-coding RNAs in neuroinflammation: characterization of LINC00520 and its possible role in Parkinson's disease, in: 2nd International Conference on Neuroprotection by Drugs, Nutraceuticals, and Physical Activity, 2021, pp. 35 - 35 (atti di: 2nd International Conference on Neuroprotection by Drugs, Nutraceuticals, and Physical Activity, Virtual edition, 9-10 dicembre 2021) [Abstract]

Sabrina Petralla, Francesca De Chirico, Andrea Miti, Ottavia Tartagni, Francesca Massenzio, Eleonora Poeta, Marco Virgili, Giampaolo Zuccheri, Barbara Monti, Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches, «BIOMOLECULES», 2021, 11, Article number: 306 , pp. 1 - 28 [Scientific article]Open Access

Albertini C.; Naldi M.; Petralla S.; Strocchi S.; Grifoni D.; Monti B.; Bartolini M.; Bolognesi M.L., From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease, «MOLECULES», 2021, 26, Article number: 1112 , pp. 1 - 22 [Scientific article]Open Access

Ruolo editoriale nella rivista «Guest editor della special Issue "Microglia in neurodegeneration" nella sezione "Molecular Biology" della rivista Biomolecules»

He F.; Chou C.J.; Scheiner M.; Poeta E.; Yuan Chen N.; Gunesch S.; Hoffmann M.; Sotriffer C.; Monti B.; Maurice T.; Decker M., Melatonin- And Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model, «JOURNAL OF MEDICINAL CHEMISTRY», 2021, 64, pp. 3794 - 3812 [Scientific article]Open Access

Gorecki L.; Uliassi E.; Bartolini M.; Janockova J.; Hrabinova M.; Hepnarova V.; Prchal L.; Muckova L.; Pejchal J.; Karasova J.Z.; Mezeiova E.; Benkova M.; Kobrlova T.; Soukup O.; Petralla S.; Monti B.; Korabecny J.; Bolognesi M.L., Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease, «ACS CHEMICAL NEUROSCIENCE», 2021, 12, pp. 1698 - 1715 [Scientific article]Open Access

Scheiner M.; Hoffmann M.; He F.; Poeta E.; Chatonnet A.; Monti B.; Maurice T.; Decker M., Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy in Vitro and in Vivo in an Alzheimer's Disease Mouse Model, «JOURNAL OF MEDICINAL CHEMISTRY», 2021, 64, pp. 9302 - 9320 [Scientific article]

Monti B., p57kip2 nuclear export as a marker of oligodendrocytes differentiation: Towards an innovative phenotyping screening for the identification of myelin repair drugs, «EBIOMEDICINE», 2021, 66, Article number: 103298 , pp. 1 - 2 [Scientific article]Open Access

Marques C.S.; Lopez O.; Bagetta D.; Carreiro E.P.; Petralla S.; Bartolini M.; Hoffmann M.; Alcaro S.; Monti B.; Bolognesi M.L.; Decker M.; Fernandez-Bolanos J.G.; Burke A.J., N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study, «BIOORGANIC CHEMISTRY», 2020, 98, Article number: 103753 , pp. 103753 - 103765 [Scientific article]

Latest news

At the moment no news are available.